Phase II Study of MLN0128 (TAK-228) in Rapalog-Resistant Advanced Pancreatic Neuroendocrine TumorsResearch & Trial Information SCHEMA EA2161 Protocol#: ECOG – EA2161 Cancer Type: GI Pancretic Eligibility: CONTINUE READING
